HEALTH AND BEAUTY CLOSE-UP-8 June 2008-CSMG Technologies Gets Fourth U.S. Tissue Bonding/Welding Patent Approval(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com
CSMG Technologies, a technology management company, announced the company has received approval of its fourth U.S. patent.The
Donald S. Robbins, President and CEO of CSMG Technologies, said, This key U.S. patent approval re-enforces our patent portfolio and expands LTC s commercial possibilities while increasing our shareholder value. Our strong patent portfolio, and a disruptive technology, puts us in an excellent position of competing and attracting interest in global medical device markets.
Currently, the LTC team is presenting comparative results with the LTC bipolar sealing system at medical conferences and showing that LTC s bipolar sealing system has broad applications. Additionally, in preparation for launching LTC s commercial product, LTC has begun production of both LTC s electro surgery generator and hand instruments for duct and vessel sealing, and opened discussions with interested international medical device companies and distributors, Robbins added.
LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC currently holds a total of approximately 31 patents and pending patents in the U.S., Australia, Canada, European Union, Ukraine and other countries.
((Comments on this story may be sent to newsdesk@closeupmedia.com))
((Distributed via M2 Communications Ltd - http://www.m2.com))